Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents
Open Access
- 1 November 2010
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 16 (11) , 1931-1939
Abstract
Background. Treatment of ulcerative proctitis has not been well studied in pediatric populations. We conducted an open-label trial to evaluate the clinical effiKeywords
This publication has 37 references indexed in Scilit:
- Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative dataGut, 2009
- Review article: medication non‐adherence in ulcerative colitis – strategies to improve adherence with mesalazine and other maintenance therapiesAlimentary Pharmacology & Therapeutics, 2008
- Review article: improving adherence to medication in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2008
- Medication-Taking Behavior in a Cohort of Patients with Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2006
- Analysis of Serum Antibodies in Patients Suspected of Having Inflammatory Bowel DiseaseClinical and Vaccine Immunology, 2006
- Children with early-onset inflammatory bowel disease (IBD): Analysis of a pediatric IBD consortium registryThe Journal of Pediatrics, 2005
- A simple clinical colitis activity indexGut, 1998
- Mesalazine Suppositories versus Hydrocortisone Foam in Patients with Distal Ulcerative Colitis:A Comparison of the Efficacy and Practicality of Two Topical Treatment RegimensScandinavian Journal of Gastroenterology, 1995
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- Rectal mucosal plasma cells in inflammatory bowel disease.Gut, 1983